Fulminant hepatic failure: A Portuguese experience

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 8, 2007, Pages 665-669

  Areia, Miguel ^a   Romãozinho, José Manuel ^a   Ferreira, Manuela ^a   Amaro, Pedro ^a   Leitão, Maximino Correia ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Acute liver failure; Fulminant hepatic failure; Liver transplantation

Indexed keywords

CYCLOSPORIN A; FENOXICAM; METHYLDOPA; NIMESULIDE; PARACETAMOL; SALAZOSULFAPYRIDINE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFECTION; CARDIOPULMONARY INSUFFICIENCY; CHILD; DISEASE CLASSIFICATION; EVOLUTION; EXPERIENCE; FEMALE; GRAFT SURVIVAL; HEPATITIS; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; VIRUS;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CHILD; FEMALE; HEPATITIS B; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34447535368     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3281ac20da     Document Type: Article

References (36)

1. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21:240-252.
2. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-954.
3. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3:282-298.
4. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342:273-275.
5. Bernuau J, Samuel D, Durand F, Saliba F, Bourlière M, Adam R, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: a prospective study [abstract]. Hepatology 1991; 14:49A.
6. Munoz SJ. Difficult management problems in fulminant hepatic failure. Semin Liver Dis 1993; 13:395-413.
7. Souto P, Romãozinho JM, Figueiredo P, Ferreira M, Sousa I, Camacho E, et al. Severe acute liver failure as the initial manifestation of haematological malignancy. Eur J Gastroenterol Hepatol 1997; 9:1113-1115.
8. Brito D, Romãozinho JM, Amaro P, Ferreira M, Neves P, Rosa A, et al. Fulminant hepatic failure-about a clinical case [in Portuguese]. GE - J Port Gastrenterol 2005; 12:167-171.
9. Roberts EA, Schilsky ML. AASLD Practice guidelines: a practice guideline on Wilson disease. Hepatology 2003; 37:1475-1492.
10. Schilsky ML. Diagnosis and treatment of Wilson's disease. Pediatr Transplant 2002; 6:15-19.
11. Rakela J, Mosley JW, Edwards VM, Govindarajan S, Alpert E. A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci 1991; 36:1223-1228.
12. Rakela J, Lange SM, Ludwig J, Baldus WP. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 1985; 60:289-292.
13. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163-169.
14. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Second Laboratory Data File (CD-ROM, Series 11, No. 2A). U.S. Department of Health and Human Services. National Center for Health Statistics. Hyattsville, Maryland: Centers for Disease Control and Prevention; 1998.
15. Polson J, Lee WM; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41:1179-1197.
16. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004; 10:1018-1023.
17. Schiodt FV, Davern TJ, Shakil AO, McGuire B, Samuel G, Lee WM. Viral hepatitis-related acute liver failure. Am J Gastroenterol 2003; 98:448-453.
18. Castells A, Salmeron JM, Navasa M, Rimola A, Salo J, Andreu H, et al. Liver transplantation for acute liver failure: analysis of applicability. Gastroenterology 1993; 105:532-538.
19. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 96:1583-1588.
20. Vickers C, Neuberger J, Buckels J, McMaster P, Elias E. Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 1988; 7:143-150.
21. Peleman RR, Gavaler JS, Van Thiel DH, Esquivel C, Gordon R, Iwatsuki S, et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987; 7:484-489.
22. Gallinger S, Greig PD, Levy G, Blendis LM, Roberts EA, Superina RA, et al. Liver transplantation for acute and subacute fulminant hepatic failure. Transplant Proc 1989; 21:2435-2438.
23. Rakela J, Perkins JD, Gross JB Jr, Hayes DH, Plevak DJ, Krom RA, et al. Acute hepatic failure: the emerging role of orthotopic liver transplantation. Mayo Clin Proc 1989; 64:424-428.
24. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-445.
25. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997; 26:62-68.
26. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 2002; 36:659-665.
27. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002; 359:558-563.
28. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol 1993; 17:124-127.
29. Cholongitas EB, Betrossian A, Leandro G, Shaw S, Patch D, Burroughs AK. King's criteria, APACHE II, and SOFA scores in acute liver failure. Hepatology 2006; 43:881.
30. Gagliardi G, Laccania G, Boscolo A, La Guardia P, Arrigoni M, Michielan F. Intensive care unit management of fulminant hepatic failure. Transplant Proc 2006; 38:1389-1393.
31. Zieniewicz K, Skwarek A, Nyckowski P, Pawlak J, Michalowicz B, Patkowski W, et al. Comparison of the results of liver transplantation for elective versus urgent indications. Transplant Proc 2003; 35:2262-2264.
32. Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al. European Liver Transplant Association. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003; 9:1231-1243.
33. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222:109-119.
34. Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation 2006; 81:195-201.
35. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, et al. European Liver Transplant Association. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006; 367:225-232.
36. Otero-Ravina F, Rodriguez-Martinez M, Selles CF, Gutierrez MG, Blanco MD, de Rituerto ST, et al. Analysis of survival after liver transplantation in Galicia, Spain. Transplant Proc 2005; 37:3913-3915.